Industry & Business

DPS wins contract for €100 million clinical manufacturing facility in the US

 Breaking News
  • Largest Ever European Investment Bank Support in Ireland The European Investment Bank is to provide a loan of €490 million to support construction of the new children’s hospital in Dublin. This represents the largest ever financial engagement by the European Union’s long-term lending institution in Ireland and the EIB’s first backing for a hospital in the country. The new children’s hospital project includes two [...]...
  • Strabane Manufacturer to Invest Over £7 Million in Ambitious Expansion Strabane-based Fabplus is planning to more than double its workforce and turnover with support from Invest Northern Ireland. The investment is part of a three year expansion plan to increase its market share in the Republic of Ireland and Great Britain, and gain a foothold in mainland Europe and Scandinavia. Recruitment is underway to employ 83 additional staff at [...]...
  • PM Group Appoints a New Non-Executive Director Michael McNicholas has been appointed as a Non-Executive Director of Project Management Holdings (PM Group), the Irish headquartered international project delivery specialists. Michael McNicholas. Michael has over 35 years’ experience in senior leadership positions in the public and private sectors. He is the former CEO of Ervia, NTR plc and Managing Director of ESB International.  During his [...]...
  • Center Parcs Signs Contract With John Sisk & Son As construction activity on the much anticipated €233 million Center Parcs Longford Forest resort in County Longford ramps up, the company has announced it has formally awarded two major construction contracts to Dublin-based construction firm John Sisk & Son. The contracts for the construction of the 470 lodges and 30 apartments as well as the state-of-the-art centre [...]...
  • Medi-Shower Invests in Innovation to Drive Export Growth Multi-award-winning manufacturer Medi-Shower has created ‘smart showerhead’ technology which can reduce the risk of Legionnaires disease. The cutting edge product, developed with R&D support from Invest Northern Ireland is designed to meet the high requirements for hygiene within the healthcare sector. It reduces the risk of waterborne infection from bacteria that can build up due to poor design [...]...

DPS wins contract for €100 million clinical manufacturing facility in the US

DPS wins contract for €100 million clinical manufacturing facility in the US
October 11
14:30 2016

Engineering group DPS, alongside its US architectural partner TRIA, has won a major contract to work on Moderna Therapeutics’ new €100 million clinical manufacturing facility in Norwood, Massachusetts.

DPS is providing full architectural and engineering design, as well as project management services, for the 200,000 sq. ft. facility. The finished site will provide Good Manufacturing Practice (GMP) standards for the clinical manufacture of mRNA therapies.

The investment in the facility is a huge one for the clinical stage biotechnology company. Moderna Therapeutics will carry out all manufacturing activities at the site, from raw material production to active pharmaceutical ingredients, formulation, filling and finish.

The full range of services that DPS and TRIA are set to offer will ensure that the Norwood facility can manufacture, control and supply clinical grade mRNA therapies, which Moderna hope can create a new generation of transformative medicines.

DPS CEO Frank Keogh says: “This is a significant contract win for DPS and builds on the strong relationship we have developed with Moderna. We are proud to be supporting Moderna with this major investment in Norwood. This project demonstrates DPS’s ability to bid for and win large-scale capital investment design projects in the US.”

If Moderna’s therapies receive regulatory approval, the Norwood site will become the manufacturing base for these therapies to be supplied to patients worldwide.

Commenting on the project, senior vice president of manufacturing and operations at Moderna, Steve Harbin, said: “This is quite an ambitious project and will result in a truly unique facility… This will be among the most integrated end-to-end process facilities I have built and seen in my 25 years working in the pharmaceutical industry.”

Construction of the site is due to begin this month, with an estimated completion date of early 2018.

About Author

admin

admin

Related Articles






New Subscriber





Subscribe Here



Advertisements
































National Manufacturing Conference & Exhibition 2016

NIBRT Springboard Success Stories



Upcoming Events

  • No upcoming events
AEC v1.0.4